Deep01

Taipei, Taiwan All Taiwan companies → — Founded 2016

Imaging AI Specialist Specialty-Focused AI

Emergency Medicine Neurology Radiology

Neurology AI Radiology & Imaging AI Triage & ER/ICU AI

Seed — $2.7M

Claim this company

Products

DeepCT

Deep01 Limited

Neurology AI

DeepCT by Deep01 Limited is an FDA-cleared AI software for the rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities from non-contrast CT scans, aiming to improve emergency workflow and patient outcomes.

Contact for details

See all 1 product →

About Deep01

Deep01 is a Taiwan-based AI software company specializing in advanced AI-based Software as a Medical Device (SaMD) for decision support, primarily focused on expediting patient treatment. The company’s flagship product, DeepCT, is an AI-driven system designed to detect and quantify brain CT images, specifically identifying abnormal scans related to intracranial hemorrhage (ICH) and other brain lesions. This technology aims to assist emergency room physicians and radiologists in prioritizing time-sensitive and life-threatening cases, thereby improving patient management during critical ‘golden hour’ periods. Deep01 is notable for being the first AI company in the world to obtain both U.S. and Taiwan FDA clearances for its deep-learning products, and has also received CE Mark, Japan PMDA, Thailand FDA, Hong Kong FDA, and Malaysia FDA clearances.

The DeepCT system has demonstrated high accuracy, with reported rates of 93% to 95% for detecting acute intracerebral hemorrhage within 30 seconds per case. Clinical trials have shown that using DeepCT can significantly reduce the length of stay for ICH patients in the emergency department, with one study reporting a reduction of 3 hours and 40 minutes on average. Beyond ICH, Deep01 is also developing capabilities for detecting brain pressure (midline shift) and skull fractures, and is working on new products for stroke and tumor detection. The company’s team comprises individuals with strong academic backgrounds from institutions like Harvard University, Cambridge University, Carnegie Mellon University, and National Taiwan University, coupled with international work experience and insights from senior physicians.

Focus Areas

AI-powered medical imaging intracranial hemorrhage detection midline shift detection brain CT image analysis decision support for physicians emergency medicine radiology neurosurgery

Business Intelligence

Key Investors	ASUS, Digital Economy Fund (co-funded by Industrial Technology Research Institute and Institute for Information Industry), BE Capital, MedTech Innovator
Partnerships	National Taiwan University Hospital, Tri-Service General Hospital, Kaohsiung Veterans General Hospital, Changhua Christian Hospital, Taipei City Hospital Wanfang Branch, Chang Gung Memorial Hospital, Show Chwan Healthcare System, Advanced Healthcare Management Corporation (AHMC), Microsoft, Nvidia, Amazon, hospitals across China, Japan, and Southeast Asia, Philippines' largest PACS provider
Acquisitions	None
Technology	AI-based Software as a Medical Device (SaMD), deep learning technology, cloud-native or in-hospital server integration
FDA Clearances	2 cleared products (estimated)

What Physicians Need to Know

AI-Powered Medical Imaging

Deep01's DeepCT system is a world-leading AI-powered detection system for head CT images, interpreting images and generating analysis reports with high accuracy (95-99.16%) in approximately 30 seconds.

Intracranial Hemorrhage (ICH) Detection

The DeepCT system accurately detects acute intracerebral hemorrhage (ICH) with reported accuracy of 93-95% and up to 99.16% in clinical trials, providing segmentation and quantification of ICH. It was the first deep learning software to obtain US FDA clearance in Asia Pacific for ICH detection.

Midline Shift Detection

Deep01's AI system is capable of detecting and quantifying midline shift, a critical indicator for neurosurgical prognosis.

Brain CT Image Analysis

The system analyzes brain CT imaging to identify and quantify various abnormal lesions, including ICH, large vessel occlusion (LVO), and fractures, offering a valuable second opinion for physicians.

Decision Support for Physicians

DeepCT streamlines workflow and empowers physicians to make faster, more critical decisions, ultimately optimizing patient outcomes by prioritizing time-sensitive cases.

Emergency Medicine, Radiology, & Neurosurgery Focus

Deep01's software is specifically designed for use in emergency departments and provides significant benefits for emergency physicians, radiologists, and neurosurgeons. Clinical trials have shown it reduces the length of stay for ICH patients in the emergency department by an average of 3 hours and 40 minutes.

Key Differentiators

Deep01 stands out due to its exceptional speed and accuracy (30 seconds for analysis with 95-99.16% accuracy for ICH detection), extensive regulatory clearances (US FDA, Taiwan FDA, Japan PMDA, CE, ISO13485, Thailand FDA, Malaysia FDA), and strong clinical validation with proven reductions in emergency department length of stay for ICH patients.

Technology Stack

The core technology is built on advanced deep learning and AI-based algorithms, delivered as Software as a Medical Device (SaMD). It processes non-contrast head CT scans (DICOM) and outputs flagged, notified, and annotated images (DICOM SC, DICOM PR). Deployment options include cloud-based, hybrid, or local dedicated hardware solutions.

Physician Tip

Deep01's DeepCT system offers physicians rapid and highly accurate (95-99.16%) analysis of brain CT scans within 30 seconds, which is crucial for time-sensitive conditions like stroke. It acts as a reliable 24/7 second opinion, enhancing diagnostic confidence, especially given the variability in human interpretation. The system not only detects intracranial hemorrhage and midline shift but also provides detailed quantification and subtyping, aiding in quicker, more informed treatment decisions. This leads to optimized workflows, prioritization of critical cases, and a clinically proven reduction in emergency department length of stay for ICH patients by an average of 3 hours and 40 minutes, directly contributing to improved patient outcomes and prognoses.

Deep01's DeepCT is designed for flexible integration, supporting standard reading environments (PACS), standalone third-party applications, and web-based solutions. The company actively explores partnerships with CT and PACS providers to ensure seamless workflow integration.

At a glance

Founded 2016

HQ Taipei, Taiwan · Taiwan

Team size 11-50

CEO David Chou

Funding Seed — $2.7M

FDA clearances 2 (estimated)

Products 1

Products by Deep01

1 product in the directory

DeepCT

Deep01 Limited

Neurology AI

Contact for details

What the Web Says

Deep01 is an AI-powered medical imaging company specializing in stroke detection. Reviews indicate strong product performance in accuracy and speed for stroke diagnosis, particularly praised by healthcare IT professionals for its potential to improve patient outcomes. Employer reviews are less prevalent but suggest a positive work environment, though specific details are limited.

Overall: Positive

Strengths

High accuracy in stroke detection
Significantly reduces diagnosis time
User-friendly interface for medical professionals
Potential to improve patient outcomes and workflow efficiency
Positive impact on emergency room operations
Innovative application of AI in healthcare

Limitations

Limited public employer reviews available
Specific pricing information not readily available in public reviews
Integration challenges with existing hospital systems (common for new tech)
Reliance on specific imaging modalities (e.g., CT scans)
Potential for over-reliance on AI by less experienced staff
Data privacy and security concerns (general for healthcare AI)

Based on reviews from: G2, Glassdoor, Healthcare IT News/Review Sites, Reddit (limited mentions), Capterra (no specific reviews found)

Last updated: 2026-07-17

Videos

News, demos, and interviews about Deep01.

Loading videos...

Videos load interactively. If none appear, search YouTube for Deep01 →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

What is Deep01's core AI-powered medical imaging product and what specific conditions does it help detect?

Deep01's primary product is DeepCT, an AI-powered software as a medical device (SaMD) designed for advanced brain CT image analysis. It specializes in detecting and quantifying critical abnormalities such as intracranial hemorrhage (ICH), midline shift, large vessel occlusion (LVO), and fractures.

How does Deep01's technology provide decision support for physicians in emergency medicine, radiology, and neurosurgery?

DeepCT assists physicians by rapidly analyzing brain CT images, typically within 30 seconds, to identify and prioritize time-sensitive and life-threatening cases. This enables emergency physicians, radiologists, and neurosurgeons to make faster, more confident decisions, expedite patient treatment, and potentially reduce the length of stay in the emergency department for ICH patients by an average of 3 hours and 40 minutes.

What regulatory clearances and compliance standards does Deep01's medical AI software meet?

Deep01 is notable for being the first AI company globally to obtain both U.S. and Taiwan FDA clearances for its technology. Additionally, Deep01 holds CE Mark, Japan PMDA, Thailand FDA, Hong Kong FDA, and Malaysia FDA clearances, demonstrating its adherence to international medical device regulations.

What are the reported accuracy and speed metrics for Deep01's brain CT image analysis?

DeepCT boasts a high diagnostic accuracy, with an overall accuracy rate of 95% for interpreting brain CT images and up to 99.16% for ICH detection in clinical trials. The system is highly efficient, capable of interpreting images and generating analysis reports within 30 seconds per case.

Can you provide information on Deep01's company stability, funding, and key partnerships?

Deep01, founded in 2017, secured $2.7 million in funding in 2020, led by ASUSTeK Computer Inc., with additional investment from Digital Economy Fund and BE Capital. The company has established partnerships with hospitals across China, Japan, Southeast Asia, and with Advanced Healthcare Management Corporation (AHMC) in the US, and its solutions are utilized in over 30 hospitals in the Asia-Pacific region.

How does Deep01's DeepCT integrate into existing hospital workflows, and what kind of support is offered?

DeepCT is designed for integration into standard reading environments like PACS, and can also function as a standalone or web-based application, supporting both cloud-based and hybrid deployment. It operates as a notification-only, parallel workflow tool, flagging suspected cases and sending alarms to clinicians to prioritize worklists. While specific support details are not publicly detailed, its widespread adoption in over 30 hospitals implies robust integration and customer support.

What is the typical pricing model for Deep01's AI-powered medical imaging solutions for healthcare institutions?

While Deep01's specific pricing model is not publicly disclosed, AI-powered MedTech solutions often utilize value-based pricing strategies. These can include subscription models for continuous access, pay-per-use arrangements based on actual device or software utilization, or outcome-based pricing where costs are tied to demonstrated clinical improvements or efficiencies.

Related Companies

Suggest an Edit →